medigraphic.com
ISSN 1561-2937 (Print)

2020, Number 2

<< Back Next >>

Rev Cubana Cardiol Cir Cardiovasc 2020; 26 (2)

Predictors for the presence of symptoms in cardiac patients with the diagnosis of Covid-19 asymptomatic upon admission

Pérez FGA, Suárez HR, Rodríguez GE, Sarda RJ

Language: Spanish
References: 20
Page: 1-7
PDF size: 233.00 Kb.


ABSTRACT

Introduction: In March 2020, Covid-19 was declared as a pandemic by the World Health Organization. The asymptomatic patient with cardiovascular morbidity poses a challenge for the worldwide public health systems. Objectives: Determine the predictors related to the further presence of symptoms in asymptomatic patient upon admission. Methods: A descriptive and cross-sectional study was carried in 32 randomly chosen cardiac patients diagnosed with Covid-19. The predictive model was developed by binary logistic regression and its calibration using the Hosmer-Lemeshow test. Results: The mean age was 59,41 years +/-20,87. The area under the ROC curve was 0,73 (p=0,028) Conclusions: The predictors related to the further presence of symptoms in asymptomatic patient upon admission were ischemic heart disease, bronchial asthma and elevated C reactive protein.


REFERENCES

  1. Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol. 2020 Mar 5. doi: 10.1002/jmv.25748. [Epub ahead of print]

  2. Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020;92(4):418‐423.

  3. Nishiura H, Kobayashi T, Miyama T, Suzuki A, Jung SM, Hayashi K, et al. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19). Int J Infect Dis. 2020 Mar 14; 94():154-155.

  4. Ministerio de Salud Pública de la República de Cuba. Conferencia de Prensa. Cubadebate. Lunes 11 de mayo de 2020; Noticias de Salud.

  5. Bi Q, Wu Y, Mei S, Ye C, Zou X, Zhang Z, et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect Dis 2020 Apr 27. pii: S1473-3099(20)30287-5. doi: 10.1016/S1473-3099(20)30287-5.

  6. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol 2020;127. DOI: https://doi.org/10.1016/j.jcv.2020.104370.

  7. ISCIII: 64ª Asamblea General. Declaración de Helsinki de la AMM -Principios éticos para las investigaciones médicas en seres humanos [Internet]. Fortaleza, Brasil: ISCIII; 2013 [citado 25 Ago 2017]: [aprox. 9 p.]. Disponible en: http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fdevaluacion/fdevaluacion-etica-investigacion/Declaracion-Helsinki-2013-Esp.pdf.

  8. Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, Yu, et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N Engl J Med. 2020 Mar 19; 382(12):1177-1179.

  9. Woelfel R, Corman VM, Guggemos W, et al. Clinical presentation and virological assessment of hospitalized cases of coronavirus disease 2019 in a travel-associated transmission cluster. medRxiv 2020 doi: 10.1101/2020.03.05.20030502.

  10. Jiang F., Deng L., Zhang L., Cai Y., Cheung C.W., Xia Z. Review of the Clinical characteristics of coronavirus disease 2019 (COVID-19) J Gen Intern Med. 2020 doi: 10.1007/s11606-020-05762-w. [online ahead of print]

  11. Babapoor-Farrokhran S, Gill D, Walker J, Rasekhi RT, Bozorgnia B, Amanullah A. Myocardial injury and COVID-19: Possible mechanisms.. Life Sci. 2020 Apr 28;253:117723. doi: 10.1016/j.lfs.2020.117723. [Epub ahead of print]

  12. Matsuyama S, Nagata N, Shirato K, Kawase M, Takeda M, Taguchi F. Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. J Virol. 2010;84:12658–64.

  13. He XW, Lai JS, Cheng J, Wang MW, Liu YJ, Xiao ZC, Xu C, Li SS, Zeng HS. [Impact of complicated myocardial injury on the clinical outcome of severe or critically ill COVID-19 patients]. Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Mar 15;48(0):E011.

  14. Bi Q, Wu Y, Mei S, Ye C, Zou X, Zhang Z, et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect Dis. 2020 Apr 27. pii: S1473-3099(20)30287-5. doi: 10.1016/S1473-3099(20)30287-5. [Epub ahead of print]

  15. Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A, Jain SS, Burkhoff D, Kumaraiah D, Rabbani Let al. Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease. Circulation. 2020 Mar 21. doi: 10.1161/CIRCULATIONAHA.120.046941.

  16. G. Seller-Pérez, M.E. Herrera-Gutiérrez, M. Lebrón-Gallardo, I. De Toro-Peinado, L. Martín-Hita, J.A. Porras-Ballesteros. Valor de la determinación de la proteína C reactiva como marcador pronóstico y de infección en pacientes críticos. Med Clin (Barc) 2005,125:761-765.

  17. Aggarwal S, Garcia-Telles N, Aggarwal G, Lavie C, Lippi G, Henry BM. Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): Early report from the United States. Diagnosis 2020; 7(2): 91–96.

  18. Fan J, Wang H, Ye G, et al. Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019. Metabolism 2020:154243.10.1016/j.metabol.2020.154243.

  19. Liu F, Li L, Xu M, Wu J, Luo D, Zhu L, Li B, Song X,et al. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol 2020;127. DOI: https://doi.org/10.1016/j.jcv.2020.104370.

  20. Aggarwal S, Garcia-Telles N, Aggarwal G, Lavie C, Lippi G, Henry BM. Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): Early report from the United States. Diagnosis 2020; 7(2): 91–96.




2020     |     www.medigraphic.com